Form 4: Bicycle Therapeutics Chief Accounting Officer Executes Stock Transactions Under 10b5-1 Plan

Bicycle Therapeutics' Chief Accounting Officer, Travis Alvin Thompson, engaged in multiple stock transactions, including both acquisitions and disposals, under a pre-arranged 10b5-1 trading plan.

Summary

• Travis Alvin Thompson, Chief Accounting Officer of Bicycle Therapeutics, executed several transactions involving the company's ordinary shares on November 11, 2024.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on August 13, 2024.
• The transactions included both the acquisition of shares through the exercise of employee stock options and the disposal of shares through sales on the open market.
• A total of 2,575 shares were acquired through option exercises at prices of $1.87, $8.21 and $9.82 per share.
• A total of 6,256 shares were sold at weighted average prices ranging from $24.77 to $25.21 per share.
• Following these transactions, Mr. Thompson directly owns 19,241 ordinary shares and 14,873 employee stock options.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of insider trading activity under a pre-arranged plan, which is neither positive nor negative for the company's prospects.

Industry Context

The filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, including those in the biotechnology sector like Bicycle Therapeutics.
• Similar filings are regularly made by executives at companies such as Amgen, Regeneron, and Gilead Sciences, reflecting routine stock transactions under pre-arranged plans.
• The reported prices for the share sales are within the typical range for market transactions, and the option exercise prices are consistent with the terms of employee stock option plans.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are part of a pre-arranged trading plan and do not indicate a change in the company's fundamentals.

Key Dates

Keywords

Bicycle Therapeutics, stock transactions, Form 4, insider trading, Rule 10b5-1, equity securities, employee stock options, share sales, Travis Alvin Thompson, Chief Accounting Officer